- Filed
- Oct 3, 2016 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2013 · Oct 1, 2016 | 96.16K sh |
| Operating Cash Flow | Q3 2013 · Sep 30, 2013 | −$1.79K |
| Operating Cash Flow | Q3 2013 · Sep 30, 2013 | −$1.82K |
| Operating Cash Flow | Q3 2013 · Sep 30, 2012 | $5.67K |
| Short Term Debt | Q3 2013 · Sep 30, 2013 | $106 |
| Short Term Debt | Q3 2013 · Dec 31, 2012 | $1.61K |
| Stockholders Equity | Q3 2013 · Sep 30, 2013 | $76.84K |
| Stockholders Equity | Q3 2013 · Dec 31, 2012 | $77.96K |
| Total Liabilities | Q3 2013 · Sep 30, 2013 | $106 |
| Total Liabilities | Q3 2013 · Dec 31, 2012 | $1.61K |
| Current Assets | Q3 2013 · Sep 30, 2013 | $73.27K |
| Current Assets | Q3 2013 · Dec 31, 2012 | $75.06K |
| Total Assets | Q3 2013 · Sep 30, 2013 | $76.95K |
| Total Assets | Q3 2013 · Dec 31, 2012 | $79.56K |
| Sga Expense | Q3 2013 · Sep 30, 2013 | −$1.86K |
| Sga Expense | Q3 2013 · Sep 30, 2013 | −$37.16K |
| Sga Expense | Q3 2013 · Sep 30, 2012 | $835 |
| Sga Expense | Q3 2013 · Sep 30, 2012 | $10.32K |
| Net Income | Q3 2013 · Sep 30, 2013 | −$1.12K |
| Net Income | Q3 2013 · Sep 30, 2013 | −$3.8K |
| Net Income | Q3 2013 · Sep 30, 2012 | $2.29K |
| Net Income | Q3 2013 · Sep 30, 2012 | $1.73K |
| Gross Profit | Q3 2013 · Sep 30, 2013 | $605 |
| Gross Profit | Q3 2013 · Sep 30, 2013 | $32.83K |
| Gross Profit | Q3 2013 · Sep 30, 2012 | $4.32K |
| Gross Profit | Q3 2013 · Sep 30, 2012 | $12.82K |
| Cost Of Revenue | Q3 2013 · Sep 30, 2013 | $1.2K |
| Cost Of Revenue | Q3 2013 · Sep 30, 2013 | $3.09K |
| Revenue | Q3 2013 · Sep 30, 2013 | $1.8K |
| Revenue | Q3 2013 · Sep 30, 2013 | $35.92K |
| Revenue | Q3 2013 · Sep 30, 2012 | $4.32K |
| Revenue | Q3 2013 · Sep 30, 2012 | $12.82K |
| Cash And Equivalents | Q3 2013 · Dec 31, 2012 | $75.06K |
| Cash And Equivalents restated | Q3 2013 · Sep 30, 2012 | $79.33K |
| Cash And Equivalents | Q3 2013 · Dec 31, 2011 | $80.79K |